17-67087002-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_014877.4(HELZ):āc.5321T>Cā(p.Val1774Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_014877.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HELZ | NM_014877.4 | c.5321T>C | p.Val1774Ala | missense_variant | 32/33 | ENST00000358691.10 | NP_055692.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HELZ | ENST00000358691.10 | c.5321T>C | p.Val1774Ala | missense_variant | 32/33 | 1 | NM_014877.4 | ENSP00000351524.5 | ||
HELZ | ENST00000580168.5 | c.5324T>C | p.Val1775Ala | missense_variant | 32/33 | 1 | ENSP00000464512.1 | |||
HELZ | ENST00000579953.5 | n.*1988T>C | non_coding_transcript_exon_variant | 30/31 | 2 | ENSP00000463727.1 | ||||
HELZ | ENST00000579953.5 | n.*1988T>C | 3_prime_UTR_variant | 30/31 | 2 | ENSP00000463727.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152068Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249584Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135408
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727230
GnomAD4 genome AF: 0.000263 AC: 40AN: 152186Hom.: 0 Cov.: 31 AF XY: 0.000229 AC XY: 17AN XY: 74398
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at